The predominant proteins that react to the MC-20 estrogen receptor alpha antibody differ in molecular weight between the mammary gland and uterus in the mouse and rat

International Journal of Biomedical Science

Volumn 8, Issue 1, 2012, Pages 51-63

  Bollig Fischer, Aliccia ^a   Thakur, Archana ^a   Sun, Yuan ^b   Wu, Jiusheng ^a   Joshua Liao, D ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Breast cancer; Estrogen receptor alpha; Mammary gland; Uterus

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA ANTIBODY; ISOPROTEIN; MC 20 ANTIBODY; MC 20 REACTIVE PROTEIN; MESSENGER RNA; PROTEIN VARIANT; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CARBOXY TERMINAL SEQUENCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INVOLUTION; LACTATION; MAMMARY GLAND; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NULLIPARA; OVARIECTOMY; PREGNANCY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; TUMOR GROWTH; UTERUS; WEIGHT; WILD TYPE;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS; RATTUS; RODENTIA;

EID: 84859044183     PISSN: 15509702     EISSN: 15552810     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Stingl J. Estrogen and progesterone in normal mammary gland development and in cancer. Horm. Cancer. 2011; 2: 85-90.
2. Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J. SteroidBiochem. Mol. Biol. 2006; 102: 89-96.
3. Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation. 2011; 82: 184-199.
4. Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer biology and therapy. Nat. Rev. Cancer. 2011; 11: 597-608.
5. Liao DZ, Pantazis CG, Hou X, Li SA. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors. Carcinogenesis. 1998; 19: 2173-2180.
6. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, et al. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 2002; 22: 8391-8401.
7. Liao DJ, Dickson RB. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J. Steroid Biochem. Mol. Biol. 2002; 80: 175-189.
8. Kos M, Denger S, Reid G, Korach KS, et al. Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse. J. Mol. Endocrinol. 2002; 29: 281-286.
9. Pendaries C, Darblade B, Rochaix P, Krust A, et al. The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc. Natl. Acad. Sci. U.S.A. 2002; 99: 2205-2210.
10. Toran-Allerand CD. Minireview: A plethora of estrogen receptors in the brain: where will it end? Endocrinology. 2004; 145: 1069-1074.
11. Shao R, Egecioglu E, Weijdegard B, Kopchick JJ, et al. Dynamic regulation of estrogen receptor-alpha isoform expression in the mouse fallopian tube: mechanistic insight into estrogen-dependent production and secretion of insulin-like growth factors. Am. J. Physiol Endocri-nol. Metab. 2007; 293: E1430-E1442.
12. Saji S, Jensen EV, Nilsson S, Rylander T, et al. Estrogen receptors alpha and beta in the rodent mammary gland. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 337-342.
13. Rost NS, Murphy K, Hafer L, Pavao M, et al. Immunochemical analyses of estrogen receptors in human breast tumors by a novel monoclonal estrogen receptor antibody (EVG F9). Steroids. 2000; 65: 429-436.
14. Li SA, Weroha SJ, Tawfik O, Li JJ. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J. Endocrinol. 2002; 175: 297-305.
15. Li JJ, Li SA. Causation and prevention of solely estrogen-induced oncogenesis: similarities to human ductal breast cancer. Adv. Exp. Med. Biol. 2003; 532: 195-207.
16. Liao DZ, Porsch-Hallstrom I, Gustafsson JA, Blanck A. Persistent sex differences in growth control of early rat liver lesions are programmed during promotion in the resistant hepatocyte model. Hepatology. 1996; 23: 835-839.
17. Liao DJ, Natarajan G, Deming SL, Jamerson MH, et al. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Oncogene. 2000; 19: 1307-1317.
18. Liao DJ, Dickson RB. Cell death in MMTV-c-myc transgenic mouse mammary tumors may not be typical apoptosis. Lab. Invest. 2003; 83: 1437-1449.
19. Asaithambi A, Mukherjee S, Thakur MK. Expression of 112-kDa estrogen receptor in mouse brain cortex and its autoregulation with age. Biochem. Biophys. Res. Commun. 1997; 231: 683-685.
20. Nawaz Z, Lonard DM, Dennis AP, Smith CL, et al. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 1858-1862.
21. Stirone C, Duckles SP, Krause DN. Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. Am. J. Physiol. Endocrinol. Metab. 2003; 284: E184-E192.
22. Leclercq G. Molecular forms of the estrogen receptor in breast cancer. J. Steroid Biochem. Mol. Biol. 2002; 80: 259-272.
23. Maaroufi Y, Trivedi S, Leclercq G. Major molecular weight heterogeneity of estrogen receptor from breast cancer is not related to neopla-sia. Cancer Biochem. Biophys. 1995; 15: 67-78.
24. Maaroufi Y, Lacroix M, Lespagnard L, Journe F, et al. Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis. Breast Cancer Res. 2000; 2: 444-454.
25. Ward RD, Weigel NL. Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation. Biofactors. 2009; 35: 528536.
26. Murphy LC, Seekallu SV, Watson PH. Clinical significance of estrogen receptor phosphorylation. Endocr. Relat. Cancer. 2011; 18: R1-14.
27. Shellabarger CJ, Stone JP, Holtzman S. Rat differences in mammary tumor induction with estrogen and neutron radiation. J. Natl. Cancer Inst. 1978; 61: 1505-1508.
28. Stygar D, Westlund P, Eriksson H, Sahlin L. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mono-nuclear leucocytes. Clin. Endocrinol. (Oxf). 2006; 64: 74-81.
29. Geisler JG, Zawalich W, Zawalich K, Lakey JR, et al. Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes. 2002; 51: 2158-2169.
30. Lu B, Dotzlaw H, Leygue E, Murphy LJ, et al. Estrogen receptor-alpha mRNA variants in murine and human tissues. Mol. Cell. Endocrinol. 1999; 158: 153-161.
31. Pasqualini C, Guivarc'h D, Boxberg YV, Nothias F, et al. Stage- and region-specific expression of estrogen receptor alpha isoforms during ontogeny of the pituitary gland. Endocrinology. 1999; 140: 2781-2789.
32. Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF. Expression of an estrogen receptor alpha variant protein in cell lines and tumors. Mol. Cell Endocrinol. 2000; 162: 167-180.
33. El KA, Journe F, Laios I, Seo HS, et al. Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells. Steroids. 2000; 65: 903-913.
34. Horvath G, Leser G, Hahlin M, Henriksson M. Exon deletions and variants of human estrogen receptor mRNA in endometrial hyperpla-sia and adenocarcinoma. Int. J. Gynecol. Cancer. 2000; 10: 128-136.
35. Taylor SE, Martin-Hirsch PL, Martin FL. Oestrogen receptor splice variants in the pathogenesis of disease. Cancer Lett. 2010; 288: 133148.
36. Reid G, Denger S, Kos M, Gannon F. Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. Cell Mol. Life Sci. 2002; 59: 821-831.
37. Ishunina TA, Swaab DF. Estrogen receptor-alpha splice variants in the human brain. Gynecol. Endocrinol. 2008; 24: 93-98.
38. Denger S, Reid G, Kos M, Flouriot G, et al. ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol. Endocrinol. 2001; 15: 2064-2077.
39. Lubahn DB, Moyer JS, Golding TS, Couse JF, et al. Alteration of reproductive function but not prenatal sexual development after inser-tional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 11162-11166.
40. Couse JF, Curtis SW, Washburn TF, Lindzey J, et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 1995; 9: 1441-1454.
41. Dupont S, Krust A, Gansmuller A, Dierich A, et al. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development. 2000; 127: 4277-4291.
42. Van Der KK, Beyaert R, Inze D, De VL. Translational control of eukaryotic gene expression. Crit. Rev. Biochem. Mol. Biol. 2009; 44: 143-168.
43. Iacono M, Mignone F, Pesole G. uAUG and uORFs in human and rodent 5'untranslated mRNAs. Gene. 2005; 349: 97-105.
44. Ivanov IP, Atkins JF, Michael AJ. A profusion of upstream open reading frame mechanisms in polyamine-responsive translational regulation. Nucleic Acids Res. 2010; 38: 353-359.
45. Shatsky IN, Dmitriev SE, Terenin IM, Andreev DE. Cap- and IRES- independent scanning mechanism of translation initiation as an alternative to the concept of cellular IRESs. Mol. Cells 2010; 30: 285-293.
46. Barraille P, Chinestra P, Bayard F, Faye JC. Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ERalpha. Biochem. Biophys. Res. Commun. 1999; 257: 84-88.
47. King HA, Cobbold LC, Willis AE. The role of IRES trans-acting factors in regulating translation initiation. Biochem. Soc. Trans. 2010; 38: 1581-1586.
48. Spriggs KA, Stoneley M, Bushell M, Willis AE. Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol. Cell 2008; 100: 27-38.
49. Pentecost BT, Song R, Luo M, DePasquale JA, et al. Upstream regions of the estrogen receptor alpha proximal promoter transcript regulate ER protein expression through a translational mechanism. Mol. Cell. Endocrinol. 2005; 229: 83-94.
50. Kos M, Denger S, Reid G, Gannon F. Upstream open reading frames regulate the translation of the multiple mRNA variants of the estrogen receptor alpha. J. Biol. Chem. 2002; 277: 37131-37138.
51. Nyiko T, Sonkoly B, Merai Z, Benkovics AH, et al. Plant upstream ORFs can trigger nonsense-mediated mRNA decay in a size-dependent manner. Plant Mol. Biol. 2009; 71: 367-378.
52. Griffin C, Flouriot G, Sonntag-Buck V, Gannon F. Two functionally different protein isoforms are produced from the chicken estrogen receptor-alpha gene. Mol. Endocrinol. 1999; 13: 1571-1587.
53. Claret FX, Chapel S, Garces J, Tsai-Pflugfelder M, et al. Two functional forms of the Xenopus laevis estrogen receptor translated from a single mRNA species. J. Biol. Chem. 1994; 269: 14047-14055.
54. Orlando L, Schiavone P, Fedele P, Calvani N, et al. Molecularly targeted endocrine therapies for breast cancer. Cancer Treat. Rev. 2010; 36 Suppl 3: S67-S71.